• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    More On GLAXO.NS



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    GlaxoSmithkline Pharmaceuticals Limited (GLAXO.NS)

    3,347.40 Down 4.60(0.14%) Jul 3, 5:59AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    GlaxoSmithkline Pharmaceuticals Limited
    Dr. Annie Besant Road
    Mumbai, 400030
    India - Map
    Phone: 91 22 2495 9595
    Fax: 91 22 2495 9494
    Website: http://www.gsk-india.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Major
    Full Time Employees:N/A

    Business Summary 

    GlaxoSmithKline Pharmaceuticals Limited operates as research-based healthcare and pharmaceutical company worldwide. It manufactures, distributes, and trades prescription medicines for a range of therapeutic areas, including analgesic, anti-infective, anti-inflammatory, anti-parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, CNS, and oncology diseases. The company also offers vaccines for the prevention of various diseases comprising hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia, and others. GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 and is based in Mumbai, India.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on GlaxoSmithkline Pharmaceuticals Limited

    Key Executives 
    Dr. Hasit B. Joshipura ,
    Managing Director, Exec. Director and Member of Investors/Shareholders Grievance Committee
    Mr. Raju Krishnaswamy ,
    Exec. Director of Technical and Exec. Director
    Mr. Ronald C. Sequeira ,
    Exec. Director of HR and Exec. Director
    Mr. Andrew Aristidou ,
    Chief Financial Officer and Exec. Director
    Mr. Ajay A. Nadkarni ,
    Gen. Mang. of Admin., Compliance Officer and Company Sec.
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in INR.